Radial Bests Femoral Access for Coronary Interventions

This article originally appeared here.
Share this content:
Radial Bests Femoral Access for Coronary Interventions
Radial Bests Femoral Access for Coronary Interventions

THURSDAY, July 7, 2016 (HealthDay News) -- Compared with femoral access for coronary interventions, radial access reduces mortality and major adverse cardiovascular endpoints (MACE) across the spectrum of patients with coronary artery disease (CAD), according to a review published in the June issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.

Giuseppe Ferrante, M.D., Ph.D., from the Humanitas Clinical and Research Center in Italy, and colleagues conducted a systematic literature review to identify randomized trials comparing radial and femoral access for coronary interventions.

The researchers identified 24 studies (22,843 participants). They found that compared with femoral access, radial access was associated with a significantly lower risk of all-cause mortality (odds ratio [OR], 0.71), MACE (OR, 0.84), major bleeding (OR, 0.53), and major vascular complications (OR, 0.23). The two groups had similar rates of myocardial infarction and stroke. Across the whole spectrum of CAD patients, the effects of radial access were consistent.

"These findings support the use of the radial access as the default approach for patients undergoing coronary interventions," conclude the authors.

Two authors report financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »